Atlas Trials

AD 32 With or Without BCG After Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder Cancer

Clinical trial NCT00003759 · COMPLETED

Trial details

NCT number
NCT00003759
Sponsor
Anthra Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Bladder Cancer
Start date
1998-11-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.